CORT
CORCEPT THERAPEUTICS INC
+0.50 (+0.45%)112.31USD212K成交股數12.1B市值267.4本益比(近四季)14.6股價營收比+31.7%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 256M+63% | 165M-9% | 208M+14% | 194M+19% | 157M+7% | 182M+47% | 183M+55% | 164M+55% | 147M | 124M | 118M | 106M |
| 營業成本 | 4.1M | 2.9M | 4.6M | 3.4M | 2.4M | 3.0M | 2.9M | 2.5M | 2.5M | 1.6M | 1.6M | 1.4M |
| 毛利 | 252M+63% | 162M-9% | 203M+13% | 191M+18% | 155M+7% | 179M+47% | 180M+55% | 161M+55% | 144M | 122M | 116M | 104M |
| 毛利率 | 98.4% | 98.3% | 97.8% | 98.2% | 98.5% | 98.4% | 98.4% | 98.5% | 98.3% | 98.7% | 98.7% | 98.7% |
| 研發費用 | 53.9M | 66.3M | 68.8M | 60.5M | 60.7M | 70.3M | 59.3M | 58.7M | 58.5M | 45.5M | 43.3M | 40.9M |
| 銷售管理費用 | 157M | 145M | 124M | 104M | 90.7M | 83.4M | 73.7M | 66.9M | 56.3M | 45.3M | 43.3M | 48.6M |
| 營業利益 | 41.3M+1109% | −49.6M-296% | 10.2M-78% | 26.7M-25% | 3.4M-88% | 25.3M-19% | 46.6M+58% | 35.6M+140% | 29.5M | 31.2M | 29.6M | 14.9M |
| 營業利益率 | 16.1% | -30.1% | 4.9% | 13.7% | 2.2% | 13.9% | 25.5% | 21.7% | 20.1% | 25.2% | 25.1% | 14.1% |
| 稅後淨利 | 43.0M+109% | −31.8M-203% | 19.7M-58% | 35.1M-1% | 20.5M-26% | 30.7M-2% | 47.2M+72% | 35.5M+123% | 27.8M | 31.4M | 27.5M | 15.9M |
| 淨利率 | 16.8% | -19.3% | 9.5% | 18.1% | 13.1% | 16.9% | 25.9% | 21.7% | 18.9% | 25.4% | 23.4% | 15.0% |
| 稀釋 EPS | 0.36+112% | -0.30-220% | 0.16-61% | 0.29-9% | 0.17-32% | 0.25-11% | 0.41+64% | 0.32+129% | 0.25 | 0.28 | 0.25 | 0.14 |
| 稀釋股數 | 118M | 104M | 119M | 120M | 120M | 113M | 114M | 111M | 110M | 111M | 110M | 115M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 111M | 109M | 125M | 103M | 89.8M | 128M | 137M | 129M | 150M | 112M | 172M | 300M |
| 應收帳款 | 76.9M | 39.1M | 69.6M | 64.6M | 61.8M | 54.0M | 59.7M | 53.8M | 61.5M | 34.6M | 32.6M | 32.6M |
| 存貨 | 13.2M | 12.9M | 12.3M | 12.3M | 14.4M | 12.4M | 8.1M | 8.4M | 7.2M | 7.5M | 6.9M | 6.4M |
| 總資產 | 889M | 815M | 824M | 802M | 846M | 841M | 784M | 715M | 656M | 594M | 525M | 618M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 183M | 177M | 192M | 166M | 163M | 161M | 145M | 118M | 108M | 132M | 103M | 88.3M |
| 股東權益 | 706M | 638M | 632M | 636M | 683M | 680M | 639M | 596M | 548M | 462M | 422M | 530M |
| 負債比 | 20.6% | 21.7% | 23.3% | 20.7% | 19.3% | 19.1% | 18.5% | 16.6% | 16.5% | 22.3% | 19.6% | 14.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −16.8M | – | – | 4.8M-80% | – | – | – | 23.8M | – | – | 26.0M |
| 資本支出 | – | 201K | – | – | 104K | – | – | – | 0.00 | – | – | 0.00 |
| 自由現金流 | – | −17.0M | – | – | 4.7M-80% | – | – | – | 23.8M | – | – | 26.0M |
| 折舊攤銷 | – | 598K | – | – | 462K | – | – | – | 120K | – | – | 172K |
| 買回庫藏股 | – | 0.00 | – | – | 27.4M | – | – | – | 476K | – | – | 0.00 |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -10.3% | – | – | 3.0% | – | – | – | 16.2% | – | – | 24.6% |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 761M | +12.8% | 99.7M | 13.1% | 0.82 | 142M |
| FY2024 | 675M | +39.9% | 141M | 20.9% | 1.23 | 196M |
| FY2023 | 482M | +20.0% | 106M | 22.0% | 0.94 | 127M |
| FY2022 | 402M | +9.8% | 101M | 25.2% | 0.87 | 120M |
| FY2021 | 366M | +3.4% | 113M | 30.7% | 0.89 | 167M |
| FY2020 | 354M | +15.5% | 106M | 30.0% | 0.85 | 151M |
| FY2019 | 306M | +22.0% | 94.2M | 30.7% | 0.77 | 135M |
| FY2018 | 251M | – | 75.4M | 30.0% | 0.60 | 115M |